Literature DB >> 25713079

A role for the tyrosine kinase Pyk2 in depolarization-induced contraction of vascular smooth muscle.

Ryan D Mills1, Mitsuo Mita2, Jun-ichi Nakagawa2, Masaru Shoji2, Cindy Sutherland1, Michael P Walsh3.   

Abstract

Depolarization of the vascular smooth muscle cell membrane evokes a rapid (phasic) contractile response followed by a sustained (tonic) contraction. We showed previously that the sustained contraction involves genistein-sensitive tyrosine phosphorylation upstream of the RhoA/Rho-associated kinase (ROK) pathway leading to phosphorylation of MYPT1 (the myosin-targeting subunit of myosin light chain phosphatase (MLCP)) and myosin regulatory light chains (LC20). In this study, we addressed the hypothesis that membrane depolarization elicits activation of the Ca(2+)-dependent tyrosine kinase Pyk2 (proline-rich tyrosine kinase 2). Pyk2 was identified as the major tyrosine-phosphorylated protein in response to membrane depolarization. The tonic phase of K(+)-induced contraction was inhibited by the Pyk2 inhibitor sodium salicylate, which abolished the sustained elevation of LC20 phosphorylation. Membrane depolarization induced autophosphorylation (activation) of Pyk2 with a time course that correlated with the sustained contractile response. The Pyk2/focal adhesion kinase (FAK) inhibitor PF-431396 inhibited both phasic and tonic components of the contractile response to K(+), Pyk2 autophosphorylation, and LC20 phosphorylation but had no effect on the calyculin A (MLCP inhibitor)-induced contraction. Ionomycin, in the presence of extracellular Ca(2+), elicited a slow, sustained contraction and Pyk2 autophosphorylation, which were blocked by pre-treatment with PF-431396. Furthermore, the Ca(2+) channel blocker nifedipine inhibited peak and sustained K(+)-induced force and Pyk2 autophosphorylation. Inhibition of Pyk2 abolished the K(+)-induced translocation of RhoA to the particulate fraction and the phosphorylation of MYPT1 at Thr-697 and Thr-855. We conclude that depolarization-induced entry of Ca(2+) activates Pyk2 upstream of the RhoA/ROK pathway, leading to MYPT1 phosphorylation and MLCP inhibition. The resulting sustained elevation of LC20 phosphorylation then accounts for the tonic contractile response to membrane depolarization.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Depolarization; Myosin; Myosin Light Chain Phosphorylation; Protein-Tyrosine Kinase (Tyrosine-Protein Kinase); Rho (Rho GTPase); Rho-associated Kinase; Tonic Contraction; Vascular Smooth Muscle

Mesh:

Substances:

Year:  2015        PMID: 25713079      PMCID: PMC4423659          DOI: 10.1074/jbc.M114.633107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle.

Authors:  Cindy Sutherland; Michael P Walsh
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

2.  Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells.

Authors:  Andrea Murányi; Dmitry Derkach; Ferenc Erdodi; Andrea Kiss; Masaaki Ito; David J Hartshorne
Journal:  FEBS Lett       Date:  2005-11-09       Impact factor: 4.124

Review 3.  Excitation-contraction coupling in gastrointestinal and other smooth muscles.

Authors:  T B Bolton; S A Prestwich; A V Zholos; D V Gordienko
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

Review 4.  The biochemical basis of the regulation of smooth-muscle contraction.

Authors:  B G Allen; M P Walsh
Journal:  Trends Biochem Sci       Date:  1994-09       Impact factor: 13.807

Review 5.  Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus.

Authors:  Paul H Ratz; Krystina M Berg; Nicole H Urban; Amy S Miner
Journal:  Am J Physiol Cell Physiol       Date:  2005-04       Impact factor: 4.249

Review 6.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

7.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

8.  PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA.

Authors:  Zhekang Ying; Fernanda R C Giachini; Rita C Tostes; R Clinton Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10       Impact factor: 8.311

9.  Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.

Authors:  Seungil Han; Anil Mistry; Jeanne S Chang; David Cunningham; Matt Griffor; Peter C Bonnette; Hong Wang; Boris A Chrunyk; Gary E Aspnes; Daniel P Walker; Arthur D Brosius; Leonard Buckbinder
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

10.  Membrane depolarization-induced RhoA/Rho-associated kinase activation and sustained contraction of rat caudal arterial smooth muscle involves genistein-sensitive tyrosine phosphorylation.

Authors:  Mitsuo Mita; Hitoshi Tanaka; Hayato Yanagihara; Junichi Nakagawa; Shigeru Hishinuma; Cindy Sutherland; Michael P Walsh; Masaru Shoji
Journal:  J Smooth Muscle Res       Date:  2013
View more
  17 in total

Review 1.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

Review 2.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

3.  CF airway smooth muscle transcriptome reveals a role for PYK2.

Authors:  Daniel P Cook; Ryan J Adam; Keyan Zarei; Benjamin Deonovic; Mallory R Stroik; Nicholas D Gansemer; David K Meyerholz; Kin Fai Au; David A Stoltz
Journal:  JCI Insight       Date:  2017-09-07

4.  A role for focal adhesion kinase in facilitating the contractile responses of murine gastric fundus smooth muscles.

Authors:  Yeming Xie; Koon Hee Han; Nathan Grainger; Wen Li; Robert D Corrigan; Brian A Perrino
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

5.  Quantitative in situ proximity ligation assays examining protein interactions and phosphorylation during smooth muscle contractions.

Authors:  Yeming Xie; Brian A Perrino
Journal:  Anal Biochem       Date:  2019-04-11       Impact factor: 3.365

6.  A Fyn biosensor reveals pulsatile, spatially localized kinase activity and signaling crosstalk in live mammalian cells.

Authors:  Ananya Mukherjee; Randhir Singh; Sreeram Udayan; Sayan Biswas; Pothula Purushotham Reddy; Saumya Manmadhan; Geen George; Shilpa Kumar; Ranabir Das; Balaji M Rao; Akash Gulyani
Journal:  Elife       Date:  2020-02-04       Impact factor: 8.140

7.  Caveolin-1 regulates corneal wound healing by modulating Kir4.1 activity.

Authors:  Chengbiao Zhang; Xiaotong Su; Lars Bellner; Dao-Hong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-27       Impact factor: 4.249

8.  Regulation of arterial reactivity by concurrent signaling through the E-prostanoid receptor 3 and angiotensin receptor 1.

Authors:  Maria P Kraemer; Hyehun Choi; Jeff Reese; Fred S Lamb; Richard M Breyer
Journal:  Vascul Pharmacol       Date:  2016-05-31       Impact factor: 5.773

9.  Sperm-oocyte signaling: the role of IZUMO1R and CD9 in PTK2B activation and actin remodeling at the sperm binding site†.

Authors:  Huizhen Wang; Xiaoman Hong; William H Kinsey
Journal:  Biol Reprod       Date:  2021-06-04       Impact factor: 4.285

10.  MicroRNA-203 mimics age-related aortic smooth muscle dysfunction of cytoskeletal pathways.

Authors:  Christopher J Nicholson; Francesca Seta; Sophie Lee; Kathleen G Morgan
Journal:  J Cell Mol Med       Date:  2016-08-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.